Suppression of alcohol preference in high alcohol drinking rats: Efficacy of amperozide versus naltrexone

Neuropsychopharmacology

Volumn 14, Issue 2, 1996, Pages 139-149

  Myers, R D ^a   Lankford, Miles F ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

5 HT(2A) receptor antagonist; Alcogene; Alcohol preference; Amperozide; Drinking; Ethanol; Genetics; HAD rats; Naltrexone; Opiate receptors; Serotonin

Indexed keywords

ALCOHOL; AMPEROZIDE; NALTREXONE; OPIATE RECEPTOR; SEROTONIN 2A RECEPTOR;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030019888     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0893-133X(95)00081-N     Document Type: Article

References (54)

1. 2 receptor antagonist. Psychopharmacol 104:287-292
2. Barwick VS, Myers RD (1992): Age-dependent development of ethanol drinking in rats after inhibition of aldehyde dehydrogenase. Alcohol 9:501-507
3. Benjamin D, Grant ER, Pohorecky LA (1993): Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats. Brain Res 621:137-140
4. Björk A, Bergman I, Gustavsson G (1992): Amperozide in the treatment of schizophrenic patients. A preliminary report. In Meltzer HY (ed), Novel Antipsychotic Drugs. New York, Raven, pp 47-57
5. Brewerton TD, Murphy DL, Jimerson DC (1994): Test meal responses following m-chlorophenylpiperazine and L-tryptophan in bulimics and controls. Neuropsychopharmacology 11:63-71
6. Collins MA (ed), (1985): Aldehyde Adducts in Alcoholism. New York, Alan Liss
7. Cooper SJ, Turkish S (1989): Effects of naltrexone on food preference and concurrent behavioral responses in food-deprived rats. Pharmacol Biochem Behav 33:17-20
8. Critcher EC, Lin CI, Patel J, Myers RD (1983): Attenuation of alcohol drinking in tetrahydroisoquinoline-treated rats by morphine and naltrexone. Pharmacol Biochem Behav 18:225-229
9. Davis V, Walsh M (1970): Alcohol, amines and alkaloids: A possible biochemical basis for alcohol addiction. Science 167:1,005-1,007
10. 3H]-dopamine in vitro from perfused rat striatal and limbic brain areas. Pharmacol Toxicol. 66 (Suppl) 1:45-48
11. Froehlich JC, Harts J, Lumeng L, Li TK (1990): Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference. Pharmacol Biochem Behav 35:395-390
12. Gongwer MA, Murphy JM, McBride WJ, Lumeng L, and Li TK (1989): Regional brain contents of serotonin, dopamine and their metabolites in the selectively bred high-and low-alcohol drinking lines of rats. Alcohol 6:317-320
13. Grenhoff J, Tung CS, Ugedo L, Svensson T (1990): Effects of amperozide, a putative antipsychotic drug, on rat midbrain dopamine neurons recorded in vivo. Pharmacol Toxicol 66(Suppl) 1:29-33
14. Gustafsson B, Christensson E (1990): Amperozide and emotional behavior. Pharmacol Toxicol 66(Suppl) 1:34-39
15. Hubbell CL, Marglin SH, Spitalnic SJ, Abelson ML, Wild KD, Reid LD (1991): Opioidergic, serotonergic, and dopaminergic manipulations and rats' intake of a sweetened alcoholic beverage. Alcohol 8:355-367
16. Iso H, Brush RF (1991): Opposite effects of naltrexone on ETOH intake by Syracuse high and low avoidance rats. Alcohol 8:443-448
17. Kimura K, Nomikos GG, Svenson TH (1993): Effects of amperozide on psychostimulant-induced hyperlocomotion and dopamine release in the nucleus accumbens. Pharmacol Biochem Behav 44:27-36
18. Kirkham TC, Blundell JE (1987): Effects of naloxone and naltrexone on meal patterns of freely feeding rats. Pharmacol Biochem Behav 26:515-520
19. Kornet M, Goosen C, Van Ree JM (1991): Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys. Psychopharmacol 104: 367-376
20. Lankford MF, Myers RD (1994): Genetics of alcoholism: simultaneous presentation of a chocolate drink diminishes alcohol preference in high drinking HAD rats. Pharmacol Biochem Behav 49:417-425
21. Lankford MF, Roscoe AK, Pennington S, Myers RD (1991): Drinking of high concentrations of ethanol versus palatable fluids in alcohol-preferring (P) rats: Valid animal model of alcoholism. Alcohol 4:293-299
22. Le AD, Poulos CX, Quan B, Chow S (1993): The effects of selective blockade of delta and mu opiate receptors on ethanol consumption by C57BL/6 mice in a restricted access paradigm. Brain Res 630:330-332
23. Li TK, Lumeng L, Doolittle DP (1984): Alcohol preference and voluntary alcohol intakes of inbred rat strains and the national institutes of health heterogeneous stock of rats. Alcohol Clin Exp Res 8:485-486
24. Linseman MA (1989): Central versus peripheral mediation of opioid effects on alcohol consumption in free-feeding rats. Pharmacol Biochem Behav 33:407-413
25. 2 antagonist, attenuates craving for cocaine by rats. Pharmacol Biochem Behav 46:125-129
26. Melchior C, Collins M (1982): The route and significance of endogenous synthesis of alkaloids in animals. CRC Crital Rev Toxicol 9:313-356
27. Melchior CL, Myers RD (1977): Prefernce for alcohol evoked by tetrahydropapaveroline (THP) chronically infused in the cerebral ventricle of the rat. Pharmacol Biochem Behav 7:19-35
28. 2 receptor occupancy: Implications for antipsychotic action. Eur J Pharmacol 216:67-71
29. Miceli, D, Marfaing-Jallat P, Le Magnen J (1979): Nonspecific enhancement of ethanol-induced taste aversion by naloxone. Pharmacol Biochem Behav 11:391-394
30. Myers RD (1978): Psychopharmacology of alcohol. Annu Rev Pharmacol Toxicol 18:125-144
31. Myers RD (1980): Pharmacological effects of amine-aldehyde condensation products. In Rigter H, Crabbe J (eds), Alcohol Tolerance and Dependence. The Netherlands, Elsevier, pp 339-370
32. Myers RD (1985): Multiple metabolite theory, alcohol drinking and the alcogene. In Collins MA (ed), Aldehyde Adducts in Alcoholism. New York, Alan Liss, pp 201-220
33. Myers RD (1989): Isoquinolines, β-carbolines and alcohol drinking: Involvement of opioid and dopaminergic mechanisms. Experientia 45:436-443
34. Myers RD (1994): New drugs for the treatment of experimental alcoholism. Alcohol 11(6):439-451
35. Myers RD, Critcher EC (1982): Naloxone alters alcohol drinking induced in the rat by tetrahydropapaveroline (THP) infused ICV. Pharmacol Biochem Behav 16:827-836
36. Myers RD, Melchior CL (1977): Alcohol and alcoholism: Role of serotonin. In Essman WB (ed), Serotonin in Health and Disease, vol II. Physiologic Regulation and Pharmacologic Action. New York, Spectrum, pp 373-430
37. Myers RD, Privette TH (1989): A neuroanatomical substrate for alcohol drinking: Identification of tetrahydropapaveroline (THP)-reactive sites in the rat brain. Brain Res Bull 22(5):899-911
38. Myers RD, Quarfordt SD (1991): Alcohol drinking atttenuated by sertraline in rats with 6-OHDA or 5,7-DHT lesions of N. accumbens: A caloric response? Pharmacol Biochem Behav 40:923-928
39. Myers RD, Veale WL (1968): Alcohol preference in the rat: Reduction following depletion of brain serotonin. Science 160:1,469-1471
40. Myers RD, Borg S, Mossberg, R (1986): Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey. Alcohol 3:383-388
41. Myers RD, Lankford M, Björk A (1992): Selective reduction by the 5-HT antagonist amperozide of alcohol preference induced in rats by systemic cyanamide. Pharmacol Biochem Behav 43:661-667
42. 2 receptor blockade by amperozide suppresses ethanol drinking in genetically preferring (P) rats. Pharmacol Biochem & Behav 45(3):741-747
43. 2 antagonist amperozide. Alcohol 10:117-125
44. Nation JR, Horger BA, Pugh CD, Bratton GR, Rowe LD (1990): The effects of naltrexone on cadmium-induced increases in oral ethanol self-administration. Alcohol 7:17-20
45. O'Brien CP (1994): Treatment of alcoholism as a chronic disorder. Alcohol 11:433-437
46. Pehek EA, Meltzer HY, Yamamoto BK (1993): The atypical antipsychotic drug amperozide enhances rat cortical and striatal dopamine efflux. Eur J Pharmacol 240:107-109
47. Privette TH, Hornsby RL, Myers RD (1988): Buspirone alters alcohol drinking induced in rats by tetrahydropapaveroline injected into brain monoaminergic pathways. Alcohol 2:147-152
48. Quarfordt SD, Kalmus GW, Myers RD (1991): Ethanol drinking following 6-OHDA lesions of nucleus accumbens and tuberculum olfactorium of the rat. Alcohol 8:211-217
49. 2 antagonist FG 5893. Alcohol 10:243-248
50. Spuhler K, Deitrich RA (1984): Correlative analysis of ethanol-related phenotypes in rat inbred strains. Alcohol Clin Exp Res 5:480-484
51. Svensson L, Fahlke C, Hard E, Engel JA (1993): Involvement of the serotonergic system in ethanol intake in the rat. Alcohol 10:219-224
52. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP (1992): Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876-880
53. Volpicelli JR, Davis MA, Olgin JE (1986): Naltrexone blocks the postshock increase of ethanol consumption. Life Sci 38:841-847
54. Yamamoto BK, Meltzer HY (1992): The effect of the atypical antipsychotic drug, amperozide, on carrier-mediated striatal dopamine release measured in vivo. J Pharmacol Exper Ther 263:180-185